Work with thought leaders and academic experts in pulmonary respiratory medicine

Companies can greatly benefit from working with experts in Pulmonary and Respiratory Medicine. These professionals have in-depth knowledge and experience in diagnosing and treating respiratory conditions. They can provide valuable insights and guidance in developing new treatments, medications, and medical devices. Additionally, they can contribute to research studies, clinical trials, and data analysis. Their expertise can help companies improve patient outcomes, enhance product development, and stay at the forefront of medical advancements.

Experts on NotedSource with backgrounds in pulmonary respiratory medicine include Jeffrey Townsend, Emmanouil Mentzakis, Edoardo Airoldi, Luke Connelly, Abiodun Adewuya, and Mehrdad Sheikhvatan.

Luke Connelly

Professor of Health Economics, The University of Queensland, CBEH
Most Relevant Research Interests
Other Research Interests (53)
Health economics
insurance
Public Health, Environmental and Occupational Health
Safety, Risk, Reliability and Quality
Human Factors and Ergonomics
And 48 more
About
Luke Connelly is Professor of Health Economics at the Centre for the Business and Economics of Health. He also holds a Professorial appointment (part-time) at The University of Bologna, to which he was appointed in 2017 via the Italian “Direct Call” ([link](https://www.unibo.it/sitoweb/luke.connelly/en)) process. In 2019 he was appointed as Honorary Professor at The University of Sydney. His main interests are in health economics and insurance economics and the effects of institutions (including legal constructs) on incentives and behaviour. He has also worked in other fields of applied microeconomics, including education economics and transport economics. His publications include papers in *Review of Income and Wealth*, *Health Economics*, *Journal of Health Economics*, *Journal of Risk and Insurance*, *Geneva Papers on Risk and Insurance*, *Accident Analysis and Prevention*, *Journal of Law and Medicine*, *Journal of Clinical Epidemiology*, *European Journal of Health Economics*, *International Journal of Health Economics and Finance*, *Social Science and Medicine*, *Economic Papers*, *Economic Analysis and Policy*, *Journal of Transport Economics and Policy*, *Labour Economics*, *Economics and Human Biology* as well as in a range of clinical journals, including *Lancet*. Luke has served on a number of public committees including the Medical Services Advisory Committee (MSAC), which advises the Australian Minister for Health on the safety, efficacy, effectiveness, and cost-effectiveness of new and extant listings on Australia's Medicare Benefits Schedule. He has extensive service on other public committees and taskforces as well as extensive teaching and consulting engagements with industry. Over his career he has been a chief investigator on research grants and contracts totalling more than $67m. He is a member of the Editorial Boards of European Journal of Health Economics and the International Journal on Environmental Research and Public Health. He is a member of the International Health Economics Association's Arrow Awards Committee, which awards an annual prize in honour of Nobel Laureate Kenneth Arrow for the best paper in the field. He is currently Guest Editor (with Christophe Courbage) on a Special Issue of the Geneva Papers on Risk and Insurance on Insurance and Emerging Health Risks. His current research interests include health service innovations to improve the health of people with chronic kidney disease(CKD). Ongoing interests include the economics of disability and insurance, compensable injury compensation schemes, and the determinants of health. Luke enjoys and has considerable experience teaching economics and health economics at both the graduate and undergraduate levels. In 2014 he was awarded the School of Economics Distinguished Teaching Award for his teaching on UQ's Master of Health Economics Program. In July 2016 and July 2019 he also taught summer schools in Health Economics and the Economics of Insurance at The University of Lucerne, Switzerland. Over the past 10 years he has been a chief investigator on grants totalling more than $70m.

Example pulmonary respiratory medicine projects

How can companies collaborate more effectively with researchers, experts, and thought leaders to make progress on pulmonary respiratory medicine?

Development of New Inhalation Therapies

A pharmaceutical company can collaborate with a Pulmonary and Respiratory Medicine expert to develop new inhalation therapies for respiratory conditions. The researcher can provide insights on the optimal drug delivery methods, dosage forms, and formulations to ensure maximum efficacy and patient compliance.

Evaluation of Air Pollution Effects

An environmental technology company can partner with a Pulmonary and Respiratory Medicine researcher to evaluate the effects of air pollution on respiratory health. The researcher can conduct studies to assess the impact of pollutants on lung function, identify high-risk populations, and recommend mitigation strategies.

Design of Respiratory Rehabilitation Programs

A healthcare provider can collaborate with a Pulmonary and Respiratory Medicine expert to design and implement respiratory rehabilitation programs. The researcher can develop personalized exercise plans, breathing techniques, and lifestyle modifications to improve lung function and quality of life for patients with chronic respiratory conditions.

Validation of Respiratory Diagnostic Tools

A medical device company can work with a Pulmonary and Respiratory Medicine specialist to validate and refine respiratory diagnostic tools. The researcher can conduct clinical studies to assess the accuracy, reliability, and usability of the devices, ensuring they provide accurate and timely diagnoses for respiratory conditions.

Development of Telemedicine Solutions

A healthcare technology company can collaborate with a Pulmonary and Respiratory Medicine expert to develop telemedicine solutions for remote monitoring and management of respiratory conditions. The researcher can contribute to the design of user-friendly platforms, data analysis algorithms, and remote patient monitoring devices.